CYTOKINETICS INC (CYTK)

US23282W6057 - Common Stock

64.8  -2.02 (-3.02%)

After market: 65.4001 +0.6 (+0.93%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
70.4M
26.16%		94.6M
34.38%		7.53M
-92.04%		6.535M
-13.21%
EBITDA
YoY % growth
-184.02M
-99.87%		-318.39M
-73.02%		-484.313M
-52.11%		-472.657M
2.41%
EBIT
YoY % growth
-186.3M
-98.40%		-324.2M
-74.02%		-496.205M
-53.06%		-461.981M
6.90%
Operating Margin
-264.63%-342.71%-6,589.71%-7,069.33%
EPS
YoY % growth
-2.83
-40.80%		-4.22
-49.12%		-5.45
-29.15%		-4.54
16.62%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-1.16
15.60%
Revenue
Q2Q % growth		917.612K
-80.10%
EBITDA
Q2Q % growth		-125.822M
EBIT
Q2Q % growth		-118.891M
4.48%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.38
4.83%		-0.99-0.39-39.39%
Q3 2023
Q2Q % growth		 -1.35
11.18%		-0.76-0.59-78.29%
Q2 2023
Q2Q % growth		 -1.34
-482.61%		-1.17-0.17-14.64%
Q1 2023
Q2Q % growth		 -1.38
-35.29%		-1.22-0.16-12.82%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 1.672M
-14.69%		10.985M-9.313M-84.78%
Q3 2023
Q2Q % growth		 380K
-84.92%		20.649M-20.269M-98.16%
Q2 2023
Q2Q % growth		 870K
-99.02%		5.92M-5.05M-85.30%
Q1 2023
Q2Q % growth		 4.61M
300.87%		2.131M2.479M116.33%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.3% -14.19% -0.79% -0.32%
Revenue-7.69% -27.46% -61.2% -78.38%